This hypothesis was explored in another study, which again examined postmortem tissue of individuals with AD and healthy controls, and further utilized a CRFBP antagonist (CRF6–33) to dissociate CRF from CRFBP in a rodent model (Behan et al., 1995b). The gene discussed is CRH; the disease is Alzheimer disease.